Paid Clinical Trials in Tigard, OR
As of August 2026, 18 paid clinical trials are recruiting in Tigard, Oregon. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Tigard offers studies at sites including Northwest Cancer Specialists, P.C. for conditions such as Breast Cancer, Advanced Non-Small Cell Lung Cancer, Breast Neoplasms, Urothelial Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Tigard
Trials by drug in Tigard
Filter results
17 clinical trials
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
The PREDICT Registry:
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
Top Research Study Locations in Tigard
Researchers run research studies in Tigard, OR at 14 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Northwest Cancer Specialists, P.C. | Advanced/Metastatic Urothelial Cancer, Breast Cancer, Colorectal Neoplasms | 4 |
| Northwest Cancer Specialists (Compass Oncology) | Breast Cancer, Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms | 2 |
| Advanced Research Institute - Portland | Chronic Idiopathic Constipation (CIC) | 1 |
| Advanced Research Institute - Tigard | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 1 |
| Advanced Vascular Centers | Chronic Limb-Threatening Ischemia | 1 |
| Compass Oncology | DCIS, Ductal Breast Carcinoma In Situ, Stage 0 Breast Cancer | 1 |
| Compass Oncology - Northwest Cancer Specialists | Breast Cancer | 1 |
| Compass Oncology - West | Urinary Bladder Neoplasms, Urothelial Cancer | 1 |
| Compass Oncology - West - Tigard | Epithelial Ovarian Cancer, Fallopian Tube Cancer, Neoadjuvant | 1 |
| Empower Clinical Research | Generalized Myasthenia Gravis | 1 |
| Local Institution - 007-885C | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Northwest Cancer Specialists, P.C | Advanced Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 1 |
| Oregon Outpatient Surgery Center | Lumbar Spinal Stenosis | 1 |
| USOR - NW Cancer Specs. P.C. | Endometrial Cancer, Recurrent or Progressive Endometrial Cancer | 1 |
Active & Upcoming Studies in Tigard (2026)
Recruiting trials in Tigard grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (11 active studies)
- Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309) · Phase 3 · Astellas Pharma Global Development, Inc.
- Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer · Phase 1, Phase 2 · Pfizer
Common conditions studied in Tigard
- Breast Cancer (3 active studies)
- Advanced Non-Small Cell Lung Cancer (2 active studies)
- Breast Neoplasms (2 active studies)
- Urothelial Cancer (2 active studies)
- Advanced/Metastatic Urothelial Cancer (1 active study)
- Atherosclerotic Cardiovascular Disease (ASCVD) (1 active study)
Leading research sponsors in Tigard
- Merck Sharp & Dohme LLC
- Pfizer
- AbbVie
- Ardelyx
- Astellas Pharma Global Development, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Tigard?
There are approximately 18 recruiting clinical trials in Tigard, Oregon listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Tigard pay participants?
Most recruiting trials in Tigard compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Tigard?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Tigard?
The most common conditions under active study in Tigard include Breast Cancer (3), Advanced Non-Small Cell Lung Cancer (2), Breast Neoplasms (2), Urothelial Cancer (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Tigard?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Tigard on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Tigard?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Tigard?
Recruiting research sites in Tigard include Northwest Cancer Specialists, P.C., Northwest Cancer Specialists (Compass Oncology), Advanced Research Institute - Portland, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Tigard right now?
The largest active categories in Tigard are Cancer & tumors (11). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.